AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

I.M.D. International Medical Devices

Regulatory Filings Nov 17, 2023

6320_rns_2023-11-17_b85391ae-15cc-4e4d-ac9d-60d6324781d2.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Informazione
Regolamentata n.
20289-28-2023
Data/Ora Inizio
Diffusione
17 Novembre 2023
18:46:42
Euronext Growth Milan
Societa' : I.M.D. INTERNATIONAL MEDICAL
DEVICES
Identificativo
Informazione
Regolamentata
: 183535
Nome utilizzatore :
IMDN01 - Gabriele Patelli
Tipologia : REGEM
Data/Ora Ricezione : 17 Novembre 2023 18:46:41
Data/Ora Inizio
Diffusione
: 17 Novembre 2023 18:46:42
Oggetto : DECEMBER 31, 2023 APPROVED REVENUE OUTLOOK TO
Testo del comunicato

Vedi allegato.

Press release

APPROVED REVENUE OUTLOOK TO DECEMBER 31, 2023

Grassobbio (BG), November 17 2023

The Board of Directors of I.M.D. International Medical Devices S.p.A. ("IMD" or the "Company" and its parent group the "IMD Group") - a leading international operator in the MedTech sector and in particular in diagnostic imaging systems, listed on the Euronext Growth Milan market - met today and approved the forecasted revenue figure as of December 31, 2023.

The IMD Group expects to achieve consolidated turnover in the range of €36 million to €38 million, a decrease from €41.8 million achieved in the year ended Dec. 31, 2022. On a standalone basis, it is projected a positive trend compared to the previous year for the subsidiary IMD Generators for all product lines and less dependence on intercompany sales, in line with the strategy of development on third-party customers implemented by management; a growing result is also expected for the subsidiary Intermedical thanks in particular to the increase in sales of "Surgery" devices; For Technix, the forecast turnover is down compared to 2022 due to: i) a partial drop in orders from one of the main OEM customers compared to the budget received from the same at the beginning of the fiscal year, ii) the delayed issuance of CE certification in MDR (Regulation (EU) 2017/745) of two new devices, and ii) due to the postponement to 2024 for purely bureaucratic reasons of some tenders in Italy and abroad, as already highlighted on September 29, 2023 at the time of the approval of the Consolidated Half-Yearly Financial Report as of June 30, 2023.

Aniello Aliberti, President and Chief Executive Officer of I.M.D. International Medical Devices S.p.A., commented, "The group's economic performance, which we expect to contract in 2023, shows a positive result for Intermedical and IMD Generators on the different product lines, while for Technix the concomitance of mainly exogenous factors has led to a slowdown. Corrective actions taken by management will be visible throughout 2024, in which we expect to implement the development strategies declared during the IPO process."

On November 20, 2023, 4 p.m., IMD's management will comment on the historical results and revenue forecast figures as of December 31, 2023 to analysts and investors in a video conference call. To attend register by communicating your email address to [email protected].

This press release is available in the Investor Relations/Press Releases section of www.imdgroup.it and on the SDIR eMarket track available at .

IMD Profile

I.M.D. International Medical Devices S.p.A. (ISIN: IT0005549255, ticker IMD) is the holding company of the IMD Group, which operates in the MedTech sector, and in particular in the research and development, production and distribution of a wide

***

I.M.D. International Medical Devices S.p.A. Via E. Fermi 26 - 24050 Grassobbio - BG - ITALY Tel: +39 035 65.94.811 - Fax: +39 035 65.94.899 C.F.e P.IVA IT02602490167 - REA BERGAMO 308232

range of X-Ray diagnostic systems. Through its 3 operating companies (Technix S.p.A., IMD Generators S.r.l. and Intermedical S.r.l.), the IMD Group has more than 40 years experience in the medical sector, basing its growth path on its design skills that have led to the development of highly innovative and cutting-edge solutions capable of meeting the trends and the highest quality and safety standards in the sector. The business model is divided into two main areas: X-Ray Generators (through its subsidiary IMD Generators) referring to the development, production and marketing of monoblocs, X-ray generators and control systems (crucial components for medical equipment) and X-Ray Imaging Devices (through its subsidiaries Technix and Intermedical) referring to the development, production and marketing of all medical equipment (analogue or digital) used in different medical fields such as orthopaedics, urology, emergency rooms and operating theatres.

Contacts

I.M.D. International Medical Devices Emittente Aniello Aliberti Investor Relator Manager [email protected] Tel. +39 03 53846611 Via E. Fermi, 26 – 24050 Grassobbio (BG)

Banca Akros

Euronext Growth Advisor & Specialist [email protected] Tel.: +39 02 434441 V.le Eginardo, 29 – 20149 Milano (MI)

IRTOP Consulting

Investor Relations Advisor [email protected] Media Relations Advisor [email protected] Tel. +39 02 45474883 Via Bigli, 19 - 20121 Milano (MI)

I.M.D. International Medical Devices S.p.A.

Via E. Fermi 26 - 24050 Grassobbio - BG - ITALY Tel: +39 035 65.94.811 - Fax: +39 035 65.94.899 C.F.e P.IVA IT02602490167 - REA BERGAMO 308232

Talk to a Data Expert

Have a question? We'll get back to you promptly.